Atorvastatin Calcium, a widely used cholesterol-lowering drug, interacts with certain genes in the human body. These genetic interactions can influence how the drug works, its dosage, and even the likelihood of experiencing side effects. Understanding these genetic influences can help healthcare providers personalize treatment plans for individuals. Here are some key genes that interact with Atorvastatin Calcium:
SLCO1B1: This gene helps the body process Atorvastatin Calcium. Variations in it can affect how well the drug is absorbed and eliminated from the body. This can influence the drug's effectiveness and the risk of side effects, such as muscle pain.
CYP3A4: This gene plays a role in breaking down Atorvastatin Calcium in the body. Different versions of it can affect how quickly the drug is broken down. This can impact the drug's effectiveness and may require adjustments in dosage.
APOE: This gene is involved in the body's handling of fats, including cholesterol. Variations in it can influence how well Atorvastatin Calcium lowers cholesterol levels. This can affect the drug's effectiveness in managing high cholesterol.
It is essential for healthcare providers to consider individual patient factors and understand their specific genetic profiles to make personalized treatment decisions with ATORVASTATIN CALCIUM